To overcome the many challenges associated with pediatric and patient-centric drug development, Capsugel is offering a new generation of technologies for product development that combines the benefits and flexibility of multi-particulate formulations, lipid-based technologies, and capsule delivery. Proprietary Lipid Multi-Particulate (LMP) technology offers a range of functionality (taste / odor masking, bioavailability enhancement, controlled release, ...) applicable to many formulation challenges. Combined with Coni-Snap® sprinkle capsules, specifically designed to be easily opened in order to allow drugs to be taken in soft foods, LMP technology can offer premier performance in pediatric formulations.
Richard Hart, Business Development Manager, EMEA - Capsugel
Catherine Lehmann, Senior Marketing Manager, EMEA - Capsugel
See the webinar here: